Table 1.
Treatment (n) | D1R-tmtmice | D1-MSNs analyzed | D2R-eGFP mice | D2-MSNs analyzed |
---|---|---|---|---|
Sham-lesioned saline (15) | 8 | 64 | 7 | 58 |
Sham-lesioned L-DOPA (4) | 3 | 23 | 2 | 16 |
Parkinsonian (14) | 7 | 45 | 7 | 50 |
Dyskinetic (14) | 7 | 54 | 7 | 53 |
Treatment (n) | D1R-tmtmice | D1-MSNs analyzed | D2R-eGFP mice | D2-MSNs analyzed |
---|---|---|---|---|
Sham-lesioned saline (15) | 8 | 64 | 7 | 58 |
Sham-lesioned L-DOPA (4) | 3 | 23 | 2 | 16 |
Parkinsonian (14) | 7 | 45 | 7 | 50 |
Dyskinetic (14) | 7 | 54 | 7 | 53 |